Nowadays, recombinant proteins have been produced in basic and applied studies. Several systems have been introduced for the efficient production of recombinant proteins in a large scale. The simplest one is overexpression of recombinant proteins in bacterial systems. However, one of the main disadvantages is the requirement of proper folding environment or posttranslational modification for accurate biological activity of recombinant proteins. In spite of this, using eukaryotic expression system could bypass this problem (1). To obtain robust and long-term expression in the eukaryotic systems, integration of the gene of interest should be in appropriate location in the genome of target cell. However, most of current methods for stable integration of exogenous DNA into genome involve random integration of DNA (2, 3). In random integration, the expression of recombinant protein mainly depends on the positional effects of the adjacent sequences in target chromatin (4). Therefore, painstaking screenings are required to find best cellular colonies for desired level of protein expression of the target gene. Recently, PhiC31 integrase, as a site specific recombinase, has been proven to minimize the random integration and provides a long-term expression with efficient functionality in mammal cells (5, 6) PhiC31 integrase mediates recombination between two sequences of attB and attP. If an attB site is located at the exogenous plasmid carrying the gene of interest, phiC31 integrase would be capable of integrating whole sequence of the plasmid at similar native attP sites so called pseudo attP sites in the mammalian genome. This style of site specific integration leads to robust expression levels in the cell (7, 8). This feature minimizes position effects of nearby sequences around pseudo attP sites (9). In our previous study, we used this system for the long-term overexpression of Tenecteplase protein in Chinese hamster ovary (CHO) cells (10).
Since determination of integrated site in transgenic stable cell lines is essential, we tried to identify pseudo attP site in Chinese hamster genome using an inverse PCR (IPCR) in this paper.
3. Materials and Methods
Inverse PCR has been employed successfully for amplification of unknown regions of the genomic DNA, outside the boundaries of identified sequences (11, 12). This technique involves digestion of genomic DNA with appropriate enzyme(s) (Figure 1A), creation of mini-circle DNA using self-ligation and appropriate primers to amplify known sequences at both sides of a DNA core region (12).
3.1. Cell Line
Tenecteplase producing CHO cell line (CHO+) was used in this study as was previously described (10).
3.2. Culture of CHO Cells and Genomic DNA Extraction
CHO+ and untransfected CHO cells (CHO-) were cultivated in Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F-12 (Sigma) supplemented with 10% fetal bovine serum (Gibco) and 10% CO2 at 37°C in a humid atmosphere. After 24 hours, CHO+ cells were treated with G418 (600 μg/mL, Sigma) and cultured for 3 days. Approximately 5×106 cells from each group (CHO+ and CHO-) were harvested and genomic DNA was extracted using DNeasy Blood and Tissue Kit (Qiagen) (Figure 1B). Restriction enzymes digestion and ligation were performed as follows: Five μg genomic DNA of each sample was digested with a pair of restriction enzymes, NheI and XbaI (Fermentas) (Figure 1C). For self-circularization of digested DNA in an inverse PCR (IPCR), low amounts of DNA (1, 2, 3 ng/μL-1) were used in 10 μL of the ligation reaction (TaKaRa) (Figure 1D).
3.3. PCR and Nested PCR
To detect site specific integration before starting nested PCR, a normal PCR was performed. In case of random exogenous plasmid integration in Chinese hamster genome, intact attB arm should be amplified using attR and attB-F3 primers. Otherwise site specific integration causes breakage. Sequences of the primers are listed in Table 1. The PCR program used for amplification was as follow: 94°C for 5 min, followed by 35 cycles of 94°C for 30 sec, 56°C for 30 sec, and 72°C for 45 sec and a final extension period of 72°C for 10 min. Then PCR products were subjected to 1% agarose gel (CinnaGen) in TBE buffer (90 mM Tris-HCl, 64.6 mM boric acid, 2.5 mM EDTA, pH 8.3). Nested PCR was performed for amplifying unknown regions of DNA. Five μL of ligation mixture was diluted with 15 μL dH2O, which was used as a template in the first round of PCR (PCRI) using TNK103-F and attB-F3 primers. In the second round of PCR, 1 μL of PCRI product was used as template using USP296-9F and attB-F3 primers (10, 13). The PCR program was as follows: 94°C for 10 min, followed by 35cycles of 94°C for 45 s, 56°C for 45 sec, and 72°C for 4 min and a final extension period of 72°C for 10 min. Cloning and sequencing were performed as follows: One product band was obtained from IPCR. This band was purified and ligated into a T-vector (InsTAcloneTM PCR Cloning Kit, Thermo Scientific) and was sequenced. Sequence analysis was performed by BLAST with RefSeqGene sequence databases. We have already published the isolation and characterization of a stable transformant CHO cells producing Tenecteplase using phiC31 integrase (10). To evaluate site specific recombination with phiC31 integrase, a normal PCR was designed based on the breakage of attB arms in exogenous plasmid encompassing Tenecteplase CDS, as a positive control (Figure 2A, Lane 1).
Polymerase chain reaction on CHO+ genome illustrated that attB arm was ruptured with the phiC31 integrase and the specific primers for this fragment did not amplify the expected size, (Figure 2A, Lane 3) confirming the site specific recombination occurred by phiC31 integrase in CHO+ cells. Thus, we tried to determine the pseudo attP site in the genome of CHO+ cells with an inverse PCR. First, compatible cohesive site producing restriction enzymes was used (Figure 1A and Figure C). These enzymes cut the plasmid at least in one position. Thereby, the right site of the recombination could be amplified in nested PCR (Figure 1A). After creating self-minicircle DNA in the last step of inverse PCR, we obtained one band (Figure 2A, Lane 4). BLAST analysis of the inverse PCR band sequence showed that the junctions at the site of specific recombination contained half of the attB site fused with the genomic sequence of Chinese hamster (GenBank accession number: NW_003613759.1).
We assigned the term of CHOL1 to this newly recognized pseudo attP site (Figure 2B). It has been proven that phiC31 enzyme can integrate a donor plasmid into the mammalian genome (6). Several studies have indicated that phiC31 integrase prefers identified sites that are named pseudo attP in several species including human (6, 14-17). Integration into these sites results in long-term expression of transgene in host cells (5, 6). Therefore, these sites could be assigned as a marker of site specific recombination in phiC31 integrase system. This system is feasible to produce desired proteins in CHO cells (7). In this study we tried to identify a pseudo attP site in Chinese hamster genome using inverse PCR named CHOL1. BLAST analysis indicated that CHOL1 sequence was similar to WT attP sequence reported in previous studies (18). The most identical sequence was observed in core region of the attB (TTGA) which is critical for phiC31 integrase site specific recombination (Figure 2B). This site has a homology (77%) with mouse genome sequence in chromosome 10 (NC_000076.5).
This study was funded with a grant from the Royan Institute in support of M.H. Sekhavati to obtain his Ph.D. degree from the Ferdowsi University of Mashhad. The authors would like to express their gratitude to the Royan Institute for their full supports.
Mohammad Hadi Sekhavati: Conception and design, collection and/or assembly of data, data analysis and interpretation, manuscript writing. Kianoush Dormiani: Conception and design, data analysis and interpretation. Kamran Ghaedi: Conception and design, data analysis and interpretation, manuscript writing, final approval of manuscript. Yahaya Khazaie: Conception and design, data analysis and interpretation. Morteza Hosseini: Conception and design, data analysis and interpretation. Mojtaba Tahmoorespur: Data analysis and interpretation. Mohammad Reza Nasiri: Data analysis and interpretation. Mahboubeh Foruzanfar: Technical assistance. Mohammad Hossein Nasr Esfahani: Conception and design, data analysis and interpretation, manuscript writing, final approval of manuscript.
None of the authors has any conflicts of interest to disclose and all authors support submission to this journal.
The authors would like to express their gratitude to the Royan Institute for their full supports.
1. Weikert S, Papac D, Briggs J, Cowfer D, Tom S, Gawlitzek M, et al. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nat Biotechnol. 1999;17(11):1116-21.
2. Lucas BK, Giere LM, DeMarco RA, Shen A, Chisholm V, Crowley CW. High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector. Nucleic Acids Res. 1996;24(9):1774-9.
3. Kaufman RJ. Overview of vector design for mammalian gene expression. Mol Biotechnol. 2000;16(2):151-60.
4. Kalos M, Fournier RE. Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain. Mol Cell Biol. 1995;15(1):198-207.
5. Groth AC, Olivares EC, Thyagarajan B, Calos MP. A phage integrase directs efficient site-specific integration in human cells. Proc Natl Acad Sci U S A. 2000;97(11):5995-6000.
6. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol. 2001;21(12):3926-34.
7. Thyagarajan B, Calos MP. Site-specific integration for high-level protein production in mammalian cells. Methods Mol Biol. 2005;308:99-106.
8. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Calos MP, Khavari PA. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum Gene Ther. 2003;14(9):923-8.
9. Karow M, Calos MP. The therapeutic potential of PhiC31 integrase as a gene therapy system. Expert Opin Biol Ther. 2011;11(10):1287-96.
10. Dormiani K, Khazaie Y, Forouzanfar M, Ghaedi K, Mofid MR, Karbalaie K, et al. Creation of Tenecteplase Producing CHO Cell Line Using Site Specific Integrase From φC31 phage. Cell J. 2010;12(2):208-14.
11. Ochman H, Gerber AS, Hartl DL. Genetic applications of an inverse polymerase chain reaction. Genetics. 1988;120(3):621-3.
12. Triglia T, Peterson MG, Kemp DJ. A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences. Nucleic Acids Res. 1988;16(16):8186.
13. Ou HL, Huang Y, Qu LJ, Xu M, Yan JB, Ren ZR, et al. A phiC31 integrase-mediated integration hotspot in favor of transgene expression exists in the bovine genome. FEBS J. 2009;276(1):155-63.
14. Ma QW, Sheng HQ, Yan JB, Cheng S, Huang Y, Chen-Tsai Y, et al. Identification of pseudo attP sites for phage phiC31 integrase in bovine genome. Biochem Biophys Res Commun. 2006;345(3):984-8.
15. Chalberg TW, Genise HL, Vollrath D, Calos MP. phiC31 integrase confers genomic integration and long-term transgene expression in rat retina. Invest Ophthalmol Vis Sci. 2005;46(6):2140-6.
16. Groth AC, Fish M, Nusse R, Calos MP. Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31. Genetics. 2004;166(4):1775-82.
17. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Fang M, Calos MP, et al. Stable nonviral genetic correction of inherited human skin disease. Nat Med. 2002;8(10):1166-70.
18. Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol. 2002;20(11):1124-8.